Affiliations 

  • 1 Pharmacologie cellulaire et moléculaire, Louvain Drug Research Institute, Université catholique de Louvain , Brussels, Belgium
  • 2 Department of Materials Engineering, Biomaterials and Tissue Engineering Research Group, KU Leuven , Leuven, Belgium
  • 3 Laboratory of Gene Technology, KU Leuven , Leuven, Belgium
  • 4 Laboratory for Molecular and Cellular Technology (LabMCT), Queen Astrid Military Hospital , Neder-over-Heembeek, Belgium
Microbiol Spectr, 2024 Jan 11;12(1):e0321923.
PMID: 38084971 DOI: 10.1128/spectrum.03219-23

Abstract

Biofilm-related infections are among the most difficult-to-treat infections in all fields of medicine due to their antibiotic tolerance and persistent character. In the field of orthopedics, these biofilms often lead to therapeutic failure of medical implantable devices and urgently need novel treatment strategies. This forthcoming article aims to explore the dynamic interplay between newly isolated bacteriophages and routinely used antibiotics and clearly indicates synergetic patterns when used as a dual treatment modality. Biofilms were drastically more reduced when both active agents were combined, thereby providing additional evidence that phage-antibiotic combinations lead to synergism and could potentially improve clinical outcome for affected patients.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.